Antimicrobial Agents Practice Questions

Q: Anti-HIV drug used for prevention of vertical transmission?

Nevirapine. ***Nevirapine*** - **Nevirapine** is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that was historically used in resource-limited settings for the prevention of **mother-to-child transmission (MTCT)** of HIV. - A single dose of **nevirapine** given to the mother during labor and to the neonate within 72 hours of birth was shown to significantly reduce the risk of **vertical transmission** (HIVNET 012 trial) [1]. - **Historical significance**: This was a landmark approach in the early 2000s when resources were limited. - **Current practice note**: Modern guidelines (WHO, 2023+) now recommend **combination antiretroviral therapy (cART)** for all pregnant women with HIV, rather than single-dose nevirapine, due to superior efficacy and reduced resistance risk [1]. *Lamivudine* - **Lamivudine** is a nucleoside reverse transcriptase inhibitor (NRTI) that is **part of current combination therapy regimens** for prevention of mother-to-child transmission. - It is not used alone but is a component of **cART regimens** recommended in modern PMTCT protocols. - In the historical context of this question, it was not the single-agent answer being sought. *Efavirenz* - **Efavirenz** is an NNRTI now used in HIV treatment regimens for pregnant women in current PMTCT protocols. - Previous concerns about first-trimester teratogenicity have been re-evaluated, and it is included in WHO-recommended regimens [1]. - However, in the context of single-drug prophylaxis (historical approach), nevirapine was preferred. *Tenofovir* - **Tenofovir** is a nucleotide reverse transcriptase inhibitor (NtRTI) and is the **backbone of current first-line cART regimens** for pregnant women with HIV. - It is highly effective as part of combination therapy for PMTCT. - It was not used as a single-dose prophylactic agent in the historical context of this question.

Q: What is the drug of choice for MRSA infection?

Vancomycin. ***Vancomycin*** - **Vancomycin** is the **drug of choice** for **methicillin-resistant Staphylococcus aureus (MRSA)** infections due to its activity against the resistant strain. - It works by inhibiting cell wall synthesis, targeting the **D-Ala-D-Ala** precursor in peptidoglycan. *Ciprofloxacin* - **Ciprofloxacin** is a **fluoroquinolone antibiotic** that is generally ineffective against **MRSA**. - MRSA strains are typically **resistant to ciprofloxacin** and other fluoroquinolones. *Oxacillin* - **Oxacillin** is a **beta-lactam antibiotic** in the penicillin family, specifically used for **methicillin-sensitive Staphylococcus aureus (MSSA)** infections. - It is **ineffective against MRSA** because MRSA possesses the *mecA* gene, encoding an altered penicillin-binding protein (PBP2a) that renders beta-lactams inactive. *Clindamycin* - **Clindamycin** can be used for **MRSA infections**, but it is generally reserved for **milder localized infections** or in specific cases based on susceptibility testing. - Its use often requires **D-test** to rule out **inducible clindamycin resistance**, which can lead to treatment failure.

Q: Which of the following drugs is not recommended for the treatment of P. falciparum malaria?

Ciprofloxacin. ***Ciprofloxacin*** - **Ciprofloxacin** is an antibiotic that is not effective against **Plasmodium falciparum** and is therefore not used in the treatment of malaria. - While it targets bacterial infections, it lacks the necessary antimalarial activity to clear the parasitic infection. *Quinine* - **Quinine** is an **oral antimalarial drug** that is effective against **P. falciparum**, especially in cases of multidrug resistance. - It works by inhibiting the parasite's ability to detoxify heme, leading to oxidative stress. *Artemether* - **Artemether** is an **artemisinin derivative**, a class of drugs that are highly effective and are the **first-line agents** for treating uncomplicated **P. falciparum malaria**. - It rapidly reduces parasite biomass, particularly in combination with drugs like lumefantrine. *Doxycycline* - **Doxycycline** is a **tetracycline antibiotic** that can be used as an alternative or adjunctive treatment for **P. falciparum malaria**, particularly in areas with resistance to other antimalarials. - It functions by inhibiting protein synthesis in the parasite and is commonly used for both treatment and prophylaxis.

Q: Which antibiotic is known to cause irreversible hearing loss?

Gentamicin. ***Gentamicin*** - **Gentamicin** is an **aminoglycoside antibiotic** well-known for its potential to cause **irreversible ototoxicity**, which manifests as permanent hearing loss due to damage to the **cochlear hair cells**. - The risk of ototoxicity is increased with higher doses, prolonged treatment, underlying renal impairment, and concomitant use of other ototoxic drugs. - Aminoglycosides cause concentration-dependent killing and have a narrow therapeutic window, requiring therapeutic drug monitoring. *Clarithromycin* - **Clarithromycin** is a **macrolide antibiotic** that can cause **reversible ototoxicity**, typically manifesting as temporary hearing loss or tinnitus. - Unlike aminoglycosides, the hearing impairment associated with clarithromycin usually resolves upon discontinuation of the drug. - This occurs more commonly with high doses or in patients with renal/hepatic impairment. *Vancomycin* - **Vancomycin** is a **glycopeptide antibiotic** that can cause ototoxicity, particularly when used at high doses or in combination with other ototoxic agents like aminoglycosides. - However, vancomycin-related ototoxicity is **less common and less severe** compared to aminoglycosides, and cases of permanent hearing loss are rare with modern dosing regimens. - The ototoxicity risk is primarily associated with older high-dose formulations. *None of the options* - This option is incorrect because **Gentamicin** is definitively known to cause irreversible hearing loss. - Aminoglycoside ototoxicity is a well-established and clinically significant adverse drug reaction that requires careful monitoring during therapy.

Q: Which of the following cephalosporins is most commonly associated with drug-induced thrombocytopenia?

Cefoperazone. ***Cefoperazone*** - **Cefoperazone** is most commonly associated with drug-induced thrombocytopenia among the listed cephalosporins. - It contains the **N-methylthiotetrazole (NMTT) side chain**, which is associated with two major hematological complications: - **Hypoprothrombinemia** due to interference with vitamin K metabolism (leading to bleeding) - **Immune-mediated thrombocytopenia** where the drug acts as a hapten, inducing antibody formation against platelets - Other cephalosporins with NMTT side chains (cefamandole, cefotetan, moxalactam) share similar risks. - The dual mechanism of both coagulation factor depletion and platelet destruction makes cefoperazone particularly notable for hematological adverse effects. *Ceftazidime* - **Ceftazidime** is a third-generation cephalosporin that can rarely cause thrombocytopenia through immune-mediated mechanisms. - However, the incidence is **lower compared to cefoperazone** and it lacks the NMTT side chain. - Reports exist but it is not the "most commonly associated" among cephalosporins. *Cefixime* - **Cefixime** is an oral third-generation cephalosporin with a **very low risk** of hematological side effects. - Reports of cefixime-induced thrombocytopenia are **exceedingly rare** and not commonly cited in pharmacology literature. *Cefdinir* - **Cefdinir** is an oral third-generation cephalosporin used for common bacterial infections. - Like cefixime, reports of **cefdinir-induced thrombocytopenia** are extremely rare and not a recognized common adverse effect.

Q: A woman presenting with symptoms of urinary tract infection was prescribed a drug that causes tendon rupture and arthropathy. What is the mechanism of action of the drug?

DNA gyrase inhibition. ***DNA gyrase inhibition*** - The description of a drug causing **tendon rupture** and **arthropathy** in the context of a urinary tract infection (UTI) suggests a **fluoroquinolone**. - Fluoroquinolones exert their bactericidal effect by inhibiting **bacterial DNA gyrase** (also known as topoisomerase II) and **topoisomerase IV**, thereby preventing DNA replication and repair. *Ribosomal inhibition* - This mechanism is characteristic of antibiotics like **aminoglycosides**, **tetracyclines**, and **macrolides**. - While some of these can treat UTIs, they are not typically associated with **tendon rupture** or **arthropathy** as major side effects. *Cell wall synthesis* - This is the mechanism of action for **beta-lactam antibiotics** (e.g., penicillins, cephalosporins) and **vancomycin**. - These drugs are common for UTIs but do not cause **tendon rupture** or **arthropathy**. *Inhibition of folic acid synthesis* - This mechanism is used by **sulfonamides** and **trimethoprim**, often combined as trimethoprim-sulfamethoxazole. - While effective for UTIs, these drugs are not known to cause **tendon rupture** or **arthropathy**.

Q: A 3-week-old infant presents with a cough and sore throat. The mother reports that the infant develops a paroxysm of cough followed by apnea. The total leucocyte count is >50,000 cells/μL. Based on these symptoms, which of the following drugs is the most appropriate treatment for this patient?

Azithromycin. ***Azithromycin*** - This infant's symptoms are highly suggestive of **pertussis** (whooping cough), characterized by **paroxysmal coughs** followed by **apnea** in young infants, along with **marked leukocytosis**. - **Macrolides** are the treatment of choice due to their effectiveness against *Bordetella pertussis*; **azithromycin** is preferred in infants due to better tolerability and a shorter course compared to erythromycin. *Amoxicillin* - **Amoxicillin** is a penicillin-class antibiotic primarily effective against various bacterial respiratory infections, but it has **no activity against *Bordetella pertussis***. - Using amoxicillin for pertussis would lead to **treatment failure** and a worsening of the infant's condition. *Cotrimoxazole* - While **cotrimoxazole** (trimethoprim-sulfamethoxazole) can be used as an alternative for pertussis in patients **allergic to macrolides**, it is **not the first-line treatment** in infants. - It carries a risk of **kernicterus** in newborns and young infants due to displacement of bilirubin from albumin, so it is generally avoided. *Erythromycin* - **Erythromycin** is a macrolide and is effective against *Bordetella pertussis*, but it is **associated with a higher incidence of infantile hypertrophic pyloric stenosis** when given to young infants. - Due to this adverse effect, **azithromycin** is generally preferred over erythromycin in infants for pertussis treatment.

Q: Which fluoroquinolone is contraindicated in patients with liver disease?

Pefloxacin. ***Pefloxacin*** - **Pefloxacin** is primarily metabolized by the **liver**, and its accumulation due to hepatic impairment can lead to increased toxicity and adverse effects, making it contraindicated. - Patients with **severe liver disease** are at a higher risk of experiencing elevated drug levels, leading to complications like **tendinopathy**, **CNS side effects**, or **hepatotoxicity**. *Levofloxacin* - **Levofloxacin** is predominantly excreted by the **kidneys** and only minimally metabolized by the liver, making it generally safer in patients with hepatic impairment. - While dose adjustments may be necessary in **renal dysfunction**, liver disease typically does not require significant modifications. *Ofloxacin* - **Ofloxacin** elimination is primarily **renal**, with little hepatic metabolism, thus it is generally considered safe for use in patients with liver disease. - It does not undergo extensive biotransformation in the liver, minimizing the risk of accumulation in individuals with impaired hepatic function. *Lomefloxacin* - **Lomefloxacin** is relatively safe in patients with liver disease as it is predominantly eliminated renally, similar to levofloxacin and ofloxacin. - Its metabolic pathway does not involve significant hepatic processing, reducing the concern for toxicity in individuals with compromised liver function.

Q: What is the Drug of Choice (DOC) for Onychomycosis?

Terbinafine. ***Terbinafine*** - **Terbinafine** is considered the **drug of choice** for **onychomycosis** due to its potent fungicidal activity against **dermatophytes**, which are the most common cause of nail infections [1]. - It accumulates in the nail plate at therapeutic levels, leading to high cure rates and a relatively good safety profile [2]. *Fluconazole* - While effective against some fungi, **fluconazole** is primarily fungistatic and generally less effective against dermatophytes compared to terbinafine for onychomycosis, resulting in lower cure rates [1]. - It is often preferred for **mucocutaneous candidiasis** and other systemic fungal infections [1]. *Itraconazole* - **Itraconazole** is an alternative for onychomycosis, often administered in pulse doses, but it can have more significant drug interactions and a higher risk of hepatic toxicity compared to terbinafine [1]. - Its efficacy against dermatophytes is comparable to terbinafine, but its side effect profile makes it a second-line option [1]. *Nystatin* - **Nystatin** is a topical antifungal effective primarily against **Candida species**, and is not effective against **dermatophytes**, which are the main pathogens in onychomycosis. - It is typically used for mucocutaneous candidiasis, such as oral thrush or vaginal yeast infections, and is not absorbed systemically.

Q: Drug of choice for invasive aspergillosis is

Voriconazole. ***Voriconazole*** - **Voriconazole** is the **first-line drug of choice** for the treatment of **invasive aspergillosis** due to its superior efficacy and good CNS penetration compared to other antifungals. - It works by inhibiting the fungal enzyme **14-alpha-demethylase**, disrupting ergosterol synthesis in the fungal cell membrane. *Posaconazole* - **Posaconazole** is a broad-spectrum triazole antifungal, primarily used for **prophylaxis** of invasive fungal infections in high-risk patients. - While it has activity against *Aspergillus*, it is generally considered a **second-line agent** for treatment or for salvage therapy if voriconazole fails. *Liposomal AMB* - **Liposomal amphotericin B (AMB)** is an effective antifungal for invasive aspergillosis, particularly in patients who **cannot tolerate voriconazole** or have contraindications. - It is often considered a **second-line or alternative therapy** rather than the first-line drug of choice. *Caspofungin* - **Caspofungin** is an **echinocandin** antifungal that inhibits the synthesis of **beta-(1,3)-D-glucan**, a crucial component of the fungal cell wall. - While active against *Aspergillus*, it is typically used as **salvage therapy** or in combination with other antifungals for invasive aspergillosis, not as a monotherapy first-line drug.

Question 1

Anti-HIV drug used for prevention of vertical transmission?

Accepted Answer

Nevirapine

Answer

Lamivudine

Answer

Efavirenz

Answer

Tenofovir

Question 2

What is the drug of choice for MRSA infection?

Accepted Answer

Vancomycin

Answer

Ciprofloxacin

Answer

Oxacillin

Answer

Clindamycin

Question 3

Which of the following drugs is not recommended for the treatment of P. falciparum malaria?

Accepted Answer

Ciprofloxacin

Answer

Artemether

Answer

Doxycycline

Answer

Quinine

Question 4

Which antibiotic is known to cause irreversible hearing loss?

Accepted Answer

Gentamicin

Answer

Clarithromycin

Answer

Vancomycin

Answer

None of the options

Question 5

Which of the following cephalosporins is most commonly associated with drug-induced thrombocytopenia?

Accepted Answer

Cefoperazone

Answer

Cefixime

Answer

Ceftazidime

Answer

Cefdinir

Question 6

A woman presenting with symptoms of urinary tract infection was prescribed a drug that    causes tendon rupture and arthropathy. What is the mechanism of action of the drug?

Accepted Answer

DNA gyrase inhibition

Answer

Ribosomal inhibition

Answer

Cell wall synthesis

Answer

Inhibition of folic acid synthesis

Question 7

A 3-week-old infant presents with a cough and sore throat. The mother reports that the infant develops a paroxysm of cough followed by apnea. The total leucocyte count is >50,000 cells/μL. Based on these symptoms, which of the following drugs is the most appropriate treatment for this patient?

Accepted Answer

Azithromycin

Answer

Amoxicillin

Answer

Cotrimoxazole

Answer

Erythromycin

Question 8

Which fluoroquinolone is contraindicated in patients with liver disease?

Accepted Answer

Pefloxacin

Answer

Ofloxacin

Answer

Lomefloxacin

Answer

Levofloxacin

Question 9

What is the Drug of Choice (DOC) for Onychomycosis?

Accepted Answer

Terbinafine

Answer

Fluconazole

Answer

Itraconazole

Answer

Nystatin

Question 10

Drug of choice for invasive aspergillosis is

Accepted Answer

Voriconazole

Answer

Posaconazole

Answer

Liposomal AMB

Answer

Caspofungin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?